ArticleEuropean urology2025

Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer.

Marie-Pier St-Laurent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.